Richard Paul Junghans. (2021). Technical note: The calculated real world BNT162b2 vaccine efficacy was 88% when accounting for asymptomatic cases. Taylor & Francis Group.
Chicago Style (17th ed.) CitationRichard Paul Junghans. Technical Note: The Calculated Real World BNT162b2 Vaccine Efficacy Was 88% When Accounting for Asymptomatic Cases. Taylor & Francis Group, 2021.
MLA (9th ed.) CitationRichard Paul Junghans. Technical Note: The Calculated Real World BNT162b2 Vaccine Efficacy Was 88% When Accounting for Asymptomatic Cases. Taylor & Francis Group, 2021.
Warning: These citations may not always be 100% accurate.